Blue Bell Private Wealth Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-85
Closed -$2.74K 757
2026
Q1
$2.74K Hold
85
﹤0.01% 641
2025
Q4
$3.58K Hold
85
﹤0.01% 622
2025
Q3
$2.92K Hold
85
﹤0.01% 622
2025
Q2
$2.3K Hold
85
﹤0.01% 624
2025
Q1
$2.52K Hold
85
﹤0.01% 617
2024
Q4
$3.37K Hold
85
﹤0.01% 571
2024
Q3
$2.89K Hold
85
﹤0.01% 594
2024
Q2
$1.84K Hold
85
﹤0.01% 625
2024
Q1
$1.88K Hold
85
﹤0.01% 636
2023
Q4
$2.34K Hold
85
﹤0.01% 615
2023
Q3
$1.9K Hold
85
﹤0.01% 580
2023
Q2
$2.17K Hold
85
﹤0.01% 575
2023
Q1
$1.9K Hold
85
﹤0.01% 553
2022
Q4
$2.02K Hold
85
﹤0.01% 561
2022
Q3
$1K Hold
85
﹤0.01% 716
2022
Q2
$2K Hold
85
﹤0.01% 662
2022
Q1
$2K Buy
85
+35
+70% +$1K ﹤0.01% 717
2021
Q4
$2K Buy
+50
New +$2.21K ﹤0.01% 716

Other funds holding VCYT

Blue Bell Private Wealth Management's VCYT Position: Q2 2026 in Review

Blue Bell Private Wealth Management sold out of Veracyte (VCYT) in Q2 2026, closing a stake of 85 shares — an estimated $2.74K sold.

Blue Bell Private Wealth Management first reported a position in VCYT in Q4 2021 and held it in 18 quarters. The position peaked at $3.58K in Q4 2025. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Blue Bell Private Wealth Management reported no remaining Veracyte position as of Q2 2026 after selling out during the quarter.
  • Blue Bell Private Wealth Management sold 85 Veracyte shares in Q2 2026, an estimated $2.74K.
  • Blue Bell Private Wealth Management first reported a position in Veracyte in Q4 2021 and held it in 18 quarters.
  • Blue Bell Private Wealth Management's Veracyte position peaked at $3.58K in Q4 2025.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Blue Bell Private Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.